Company intelligence / Profile preview

i3 Membrane

Radeberg, Saxony, Germanyi3membrane.de ↗

Ownership: Private
Development stage: Commercial

Overview

i3 Membrane has developed and commercialized advanced digital membrane technologies for efficient separation processes in life sciences. Their products are used in analytics, infection prevention, biotechnology, and biopharmaceutical purification workflows such as monoclonal antibody purification. No clinical trial results apply as the company does not develop therapeutics.

Modalities: DeviceNanotechnology (membranes and separation technologies)
Industry: Chemicals & Materials

Partnerships

High-Tech Gründerfonds

Beyond the preview

Go deeper on i3 Membrane.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i3 Membrane.

Explore the full profile